Published April 2, 2013
A story in The New York Times reports that a UB study has
found that a treatment that many people with multiple sclerosis had
hoped would prove effective has failed its first rigorous test, and
quotes Adnan Siddiqui, professor of neurosurgery, who led the study
and said the results surprised even the researchers because they
thought there might be some benefit to the treatment.